| Literature DB >> 30857242 |
Hema P Narra1, Abha Sahni2, Kamil Khanipov3, Yuriy Fofanov4, Sanjeev K Sahni5.
Abstract
Mediterranean spotted fever develops from an infection with Rickettsia conorii, an obligate intracellular, Gram-negative, endotheliotropic, and tick-transmitted bacterial pathogen, and is an acute, febrile illness that can progress to life-threatening complications if not diagnosed and treated early with effective antibiotics. Despite significant morbidity and mortality, little is known about changes in gene expression that determine the host responses during in vivo infection. We have investigated the transcriptional landscape of host lungs as a prominently affected organ system in an established murine model of infection by RNA-sequencing. Ingenuity pathway analysis resulted in the identification of 1332 differentially expressed genes and 292 upstream regulators. Notably, genes encoding for ubiquitin D, aconitate decarboxylase, antimicrobial peptides, calgranulins, cytokines and chemokines, and guanylate binding proteins were highly up-regulated, whereas those involved in hemoglobin biosynthesis and heme homeostasis were significantly down-regulated. Amongst response regulators, nucleotide-binding oligomerization domain-containing protein 2 and killer cell lectin-like receptors were differentially expressed, and gene clustering revealed eukaryotic initiation factor-2, oxidative phosphorylation, and ubiquitination as the predominantly activated biological pathways. Collectively, this first global transcriptomic profiling has identified R. conorii-induced regulation of novel genes and pathways in the host lungs, further in-depth investigation of which will strengthen our understanding of the pathogenesis of human rickettsioses.Entities:
Keywords: C3H/HeN mice; RNA sequencing; Rickettsia; antimicrobial peptides; calgranulins; guanylate-binding proteins; ingenuity pathway analysis; transcriptome; ubiquitination
Mesh:
Year: 2019 PMID: 30857242 PMCID: PMC6470625 DOI: 10.3390/genes10030204
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
List of the top 20 up- and down-regulated molecules in mouse lung tissue during in vivo R. conorii infection.
| Symbol | Gene Name | FDR ( | FC | Log2 FC | |
|---|---|---|---|---|---|
|
| |||||
|
| Ubiquitin D | 0 | 0 | 679.8 | 9.4 |
|
| Aconitate decarboxylase 1 | 0 | 0 | 433.9 | 8.8 |
|
| Chemokine (C-X-C motif) ligand 9 | 0 | 0 | 405.4 | 8.7 |
|
| Indoleamine 2,3-dioxygenase 1 | 0 | 0 | 332.3 | 8.4 |
|
| C-X-C motif chemokine ligand 10 | 0 | 0 | 331.6 | 8.4 |
|
| Lymphocyte antigen 6 complex, locus A | 0 | 0 | 223.2 | 7.8 |
|
| Cathelicidin antimicrobial peptide | 0 | 0 | 204 | 7.7 |
|
| Neutrophilic granule protein | 0 | 0 | 168 | 7.4 |
|
| Granzyme K | 0 | 0 | 135.7 | 7.1 |
|
| Guanylate binding protein family member 6 | 0 | 0 | 127.8 | 7 |
|
| Interferon γ | 0 | 0 | 119.8 | 6.9 |
|
| Serine (or cysteine) peptidase inhibitor, clade A, member 3G | 0 | 0 | 117.5 | 6.9 |
|
| Granzyme B | 0 | 0 | 103.9 | 6.7 |
|
| Granzyme A | 0 | 0 | 90.4 | 6.5 |
|
| Killer cell lectin like receptor G1 | 0 | 0 | 87.7 | 6.5 |
|
| Chemokine (C-C motif) ligand 7 | 0 | 0 | 83.9 | 6.4 |
|
| Chemokine (C-C motif) ligand 2 | 0 | 0 | 74.8 | 6.2 |
| T cell specific GTPase 1 | 0 | 0 | 73.4 | 6.2 | |
|
| Guanylate binding protein 5 | 0 | 0 | 59.1 | 5.9 |
|
| X-C motif chemokine ligand 1 | 0 | 0 | 52.6 | 5.7 |
|
| Calcium homeostasis modulator family member 6 | 0 | 0 | 52.2 | 5.7 |
|
| |||||
|
| Hemoglobin subunit β | 0 | 0 | −25.2 | −4.7 |
| Hemoglobin subunit α 2 | 0 | 0 | −22 | −4.5 | |
|
| 5’-aminolevulinate synthase 2 | 0 | 0 | −13.3 | −3.7 |
|
| Cytochrome P450 family 26 subfamily B member 1 | 3 × 10−7 | 0.000005 | −10.2 | −3.3 |
|
| Albumin | 0.000546 | 0.00461 | −9.2 | −3.2 |
|
| Hes related family bHLH transcription factor with YRPW motif 1 | 0 | 0 | −6.9 | −2.8 |
|
| Apelin receptor | 0 | 0 | −6.6 | −2.7 |
|
| Nuclear receptor subfamily 1 group D member 1 | 0 | 0 | −5.9 | −2.6 |
|
| Protein tyrosine phosphatase, receptor type B | 0 | 0 | −5.8 | −2.5 |
|
| Delta like canonical Notch ligand 4 | 0 | 0 | −5.7 | −2.5 |
|
| Ephrin B2 | 0 | 0 | −5.1 | −2.3 |
|
| Latent transforming growth factor β binding protein 4 | 0 | 0 | −5 | −2.3 |
|
| Hemicentin 1 | 0 | 0 | −4.9 | −2.3 |
|
| Angiopoietin like 2 | 0 | 0 | −4.7 | −2.2 |
|
| Endothelin receptor type B | 0 | 0 | −4.1 | −2 |
|
| SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2 | 0 | 0 | −4.1 | −2 |
|
| SH3 and PX domains 2A | 0 | 0 | −3.7 | −1.9 |
|
| N-deacetylase and N-sulfotransferase 1 | 0 | 0 | −3.7 | −1.9 |
|
| Insulin like growth factor binding protein 5 | 6.68 × 10−7 | 1.04 × 10−5 | −3.5 | −1.8 |
|
| Platelet derived growth factor receptor β | 0 | 0 | −3.5 | −1.8 |
FDR: False Discovery Rate; FC: Fold Change; Log2 FC: Log2 Fold Change.
Figure 1Validation of RNA-seq data by real time quantitative PCR (RT-qPCR). Total RNA from the lungs of mock-infected controls and Rickettsia conorii-infected mice was extracted by Tri-reagent, DNaseI treated, and reverse transcribed. Quantitative RT-PCR was performed using gene-specific primers and 18S rRNA as the endogenous control. Gene expression observed in RNA-seq data sets are presented as mean, and RT-qPCR as the mean ± standard error of the mean (SEM). The fold change observed in RT-qPCR is in accordance with that observed in RNA-seq data.
Figure 2Principal component analysis of gene expression in the lungs of mock-infected controls and R. conorii-infected C3H/HeN mice at three days post-infection. Green: mock-infected control, Red: R. conorii-infected.
Figure 3Hierarchical clustering of differentially expressed genes in the lungs of control and R. conorii-infected mice. Red color in the cluster indicates up-regulation and blue color in the cluster indicates down-regulation. The fold expression values presented below are in terms of log2.
List of the top 20 upstream regulators activated or inhibited during in vivo R. conorii infection.
| Regulator | Molecule Type | Activation | |
|---|---|---|---|
|
| |||
|
| Transcription regulator | 2.21 × 10−24 | 6.8 |
|
| Cytokine | 1.82 × 10−27 | 6.5 |
|
| Other | 4.13 × 10−22 | 6.3 |
|
| Transcription regulator | 1.62 × 10−24 | 5.8 |
|
| Transcription regulator | 1.62 × 10−17 | 5.7 |
|
| Other | 8.02 × 10−20 | 5.5 |
|
| Enzyme | 1.17 × 10−8 | 5.5 |
|
| Other | 5.86 × 10−12 | 5.4 |
|
| Cytokine | 3.07 × 10−9 | 5.2 |
|
| Transcription regulator | 8.56 × 10−6 | 4.9 |
|
| Other | 5.24 × 10−11 | 4.9 |
|
| Other | 1.03 × 10−9 | 4.8 |
|
| Transmembrane receptor | 4.04 × 10−16 | 4.7 |
|
| Transcription regulator | 1.88 × 10−8 | 4.6 |
|
| Cytokine | 3.54 × 10−13 | 4.6 |
|
| Kinase | 9.36 × 10−14 | 4.5 |
|
| Other | 1.04 × 10−14 | 4.3 |
|
| Other | 7.33 × 10−7 | 4.1 |
|
| Kinase | 8.43 × 10−17 | 4.1 |
|
| Transcription regulator | 2.48 × 10−9 | 4 |
|
| |||
|
| Transmembrane receptor | 1.85 × 10−19 | −7.4 |
|
| G-protein coupled receptor | 9.94 × 10−16 | −6 |
|
| Transcription regulator | 4.61 × 10−7 | −5.2 |
|
| Other | 1.19 × 10−15 | −4.6 |
|
| Other | 2.56 × 10−10 | −4 |
|
| Transcription regulator | 7.76 × 10−5 | −3.6 |
|
| Transcription regulator | 0.000721 | −3.4 |
|
| Ligand-dependent nuclear receptor | 7.27 × 10−8 | −3.4 |
|
| Transcription regulator | 0.000536 | −3.3 |
|
| Peptidase | 2.48 × 10−9 | −3.3 |
|
| Transporter | 5.75 × 10−6 | −2.9 |
|
| Enzyme | 5.08 × 10−5 | −2.9 |
|
| Phosphatase | 0.013 | −2.7 |
|
| Cytokine | 0.0151 | −2.6 |
|
| Kinase | 0.0333 | −2.6 |
|
| Enzyme | 0.00974 | −2.6 |
|
| Transcription regulator | 5.24 × 10−14 | −2.5 |
|
| Enzyme | 0.000106 | −2.4 |
|
| Transporter | 0.00048 | −2.4 |
|
| Transcription regulator | 2.32 × 10−8 | −2.3 |
List of five canonical pathways with the highest number of differentially expressed genes during in vivo R. conorii infection.
| Canonical Pathway Name | Differentially Expressed Genes/Total Number of Genes in the Pathway | |
|---|---|---|
| EIF2 Signaling | 1.54 × 10−42 | 100/205 (48.8%) |
| Oxidative Phosphorylation | 1.29 × 10−21 | 48/96 (50.0%) |
| Mitochondrial Dysfunction | 3.29 × 10−19 | 59/153 (38.6%) |
| Antigen Presentation Pathway | 3.90 × 10−18 | 23/28 (82.1%) |
| Protein Ubiquitination Pathway | 1.33 × 10−15 | 72/245 (29.4%) |